title: Will Keytruda Continue to Aid Merck's Top Line in Q3 Earnings?
source: Yahoo
date: 2025-10-10
url: https://finnhub.io/api/news?id=1bcaa6ec65ea9a1dffa2fe09554ef6a9a5ebf059817673f4c381444d1fe7f69c
MRK's Keytruda remains its dominant growth engine and is expected to have boosted its top line in the third quarter.
